High Purity Fidaxomicin CAS 873857-62-6: A Potent Antibiotic for Clostridium Difficile Infections
Experience cutting-edge antibiotic solutions with high-purity Fidaxomicin, a key agent against CDI.
Get a Quote & SampleProduct Core Value

Fidaxomicin
Fidaxomicin (CAS 873857-62-6) is a highly pure white powder antibiotic renowned for its unique mechanism of action. It selectively targets pathogenic bacteria, primarily by inhibiting bacterial RNA polymerase, offering a superior solution for combating Clostridium difficile infections (CDI).
- Discover the unique Fidaxomicin antibiotic mechanism for targeted treatment of CDI.
- Learn why buying Fidaxomicin online from reputable sources ensures high purity and efficacy.
- Understand the benefits of Fidaxomicin for CDI treatment, focusing on its effectiveness and safety profile.
- Explore the advantages of using high purity Fidaxomicin powder as a pharmaceutical intermediate.
Advantages It Brings
Targeted Action Against CDI
Fidaxomicin's non-systemic absorption means it acts directly on the site of infection, effectively fighting Clostridium difficile infections while preserving the crucial intestinal microbial flora.
Uncompromised Quality and Purity
With certifications like GMP, ISO 9001, USP, and BP, this pharmaceutical intermediate guarantees the highest standards of purity for critical applications.
Reliable Pharmaceutical Intermediate
As a trusted source for Fidaxomicin CAS 873857-62-6, we ensure a consistent supply of this vital compound for your pharmaceutical manufacturing needs.
Key Applications
Antibiotic Therapy
Leverage Fidaxomicin's potent antibacterial properties for advanced antibiotic therapy, particularly for challenging infections like CDI.
Pharmaceutical Manufacturing
Utilize high purity Fidaxomicin powder as a key pharmaceutical intermediate in the development and production of life-saving medications.
Microbiome Research
Investigate the selective action of non-systemic antibiotic absorption on the gut microbiome, advancing research in this critical area.
Drug Development
Explore new avenues in drug development with Fidaxomicin CAS 873857-62-6, focusing on its efficacy and safety in treating gastrointestinal disorders.